Do you need to stop Testosterone Replacement Therapy (TRT) with acute Deep Vein Thrombosis (DVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Should You Stop Testosterone Replacement Therapy (TRT) with Acute Deep Vein Thrombosis (DVT)?

Yes, you should stop TRT immediately when acute DVT occurs, as testosterone therapy interacts with underlying thrombophilia to cause recurrent venous thromboembolism (VTE) even with adequate anticoagulation. 1, 2

Evidence for Stopping TRT

Recurrent Thrombosis Despite Anticoagulation

  • Continuing TRT after DVT leads to recurrent thrombotic events despite therapeutic anticoagulation. In a case series, 11 thrombophilic patients on TRT experienced a second VTE after their first event while continuing testosterone, and 6 of these had a third VTE despite being adequately anticoagulated. 2

  • A 55-year-old man with lupus anticoagulant had 4 thrombotic events over 5 years (2 pulmonary emboli and 2 DVTs) while continuing testosterone-HCG therapy despite concurrent anticoagulation. After stopping HCG and maintaining warfarin, he remained free of further DVT-PE for 9 months. 1

Mechanism of TRT-Associated Thrombosis

  • TRT interacts with previously undiagnosed thrombophilia-hypofibrinolysis to precipitate VTE. Patients on TRT who developed VTE were significantly more likely to have Factor V Leiden heterozygosity (24-33% vs. 12%), lupus anticoagulant (14-33% vs. 4%), and high lipoprotein(a) (33% vs. 13%) compared to VTE controls not taking TRT. 2

  • The greatest density of thrombotic events occurs at 3 months after starting TRT, with 65% of VTE occurring within the first 8 months. 2

Standard DVT Management (With TRT Stopped)

Anticoagulation Duration

  • All patients with acute DVT should receive anticoagulation for a minimum of 3 months. 3

  • For unprovoked proximal DVT with low or moderate bleeding risk, extended anticoagulant therapy (no scheduled stop date) is suggested over stopping at 3 months. 3

  • For provoked DVT (such as TRT-associated), 3 months of anticoagulation is recommended over extended therapy once the provoking factor (TRT) is removed. 3

Choice of Anticoagulant

  • Direct oral anticoagulants (DOACs: apixaban, dabigatran, edoxaban, or rivaroxaban) are recommended over vitamin K antagonists for the treatment phase. 3

Critical Clinical Pitfalls

Do Not Continue TRT

  • The most dangerous error is continuing TRT after a first VTE. When DVT-PE occurs on TT or HCG in the presence of thrombophilia, testosterone should be stopped to prevent recurrent DVT-PE despite concurrent anticoagulation. 1

  • Anticoagulation alone does not adequately protect against recurrent thrombosis if TRT is continued, as demonstrated by multiple recurrent events in adequately anticoagulated patients. 1, 2

Consider Thrombophilia Screening

  • Before restarting TRT in the future (which is generally not recommended after VTE), screening for Factor V Leiden, lipoprotein(a), and lupus anticoagulant should be performed to identify patients at increased VTE risk with an adverse risk-to-benefit ratio for TRT. 2

Reassessment Strategy

  • After completing 3 months of anticoagulation with TRT discontinued, reassess for extended therapy based on whether the DVT is now considered provoked (by TRT) or if other unprovoked risk factors persist. 3

  • In patients who receive extended anticoagulant therapy, continuing use of treatment should be reassessed at periodic intervals (e.g., annually). 3

References

3
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the relationship between Testosterone Replacement Therapy (TRT) and pulmonary embolism?
How long should a transgender male pause testosterone (hormone replacement therapy) after a pulmonary embolism (PE)?
Is testosterone therapy safe in patients with a history of pulmonary embolism (PE)?
How to manage a 47-year-old male with a history of Deep Vein Thrombosis (DVT) and anxiety/depression who wants to discontinue Xarelto (rivaroxaban) due to headaches?
What's the next step for a 65-year-old patient with a history of provoked Deep Vein Thrombosis (DVT) on Eliquis (apixaban) for 6 months, with a negative Doppler ultrasound and elevated D-dimer levels?
What antibiotic can be given to a patient with possible pneumonia and allergies to amoxicillin, cefalexin, ciprofloxacin, levofloxacin, penicillin G, and sulfamethoxazole-trimethoprim?
What is the total testosterone level (Total Testosterone) below which Testosterone Replacement Therapy (TRT) is typically considered?
What are the adverse effects of Phenytoin (an antiepileptic medication)?
What is a suitable medication to start for chronic anxiety treatment?
What is the appropriate management for a male with dysuria and normal urine analysis?
What is the preferred antibiotic for a patient with cellulitis on chemotherapy with normal blood counts?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question